Prolonged
benzidine exposure is a known cause of urothelial
carcinoma (UC).
Benzidine-induced epithelial-to-mesenchymal transition (EMT) is critically involved in cell malignant transformation. The role of ERK1/2 in regulating
benzidine-triggered EMT has not been investigated. This study was to investigate the regulatory role of ERK1/2 in
benzidine-induced EMT. By using wound healing and transwell chamber migration assays, we found that
benzidine could increase SV-HUC-1 cells invasion activity, western blotting and Immunofluorescence showed that the expression levels of Snail, β-
catenin,
Vimentin, and MMP-2 were significantly increased, while, the expression levels of
E-cadherin, ZO-1 were decreased. To further demonstrate the mechanism in this process, we found that the phosphorylation of ERK1/2, p38, JNK and
AP-1 proteins were significantly enhanced compared to the control group (*P < 0.05). Afterward, treated with MAPK pathways inhibitors, only ERK inhibitor(U0126)could reduce the expression of EMT markers in SV-HUC-1 cells, but not p38 and JNK inhibitor(SB203580, SP600125), which indicated that
benzidine induces the epithelial-mesenchymal transition in human uroepithelial cells through ERK1/2 pathway. Taken together, findings from this study could provide into the molecular mechanisms by which
benzidine exerts its
bladder-cancer-promoting effect as well as its target intervention.